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15.HETE: Selective incorporation into inositol phospholipids of MDCK
cells. The interaction of 15-hydroxyeicosatetraenoic acid (15-HETE)
and cultured MDCK renal tubular epithelial cells was investigated to
determine whether incorporation of this lipoxygenase product will
affect polyphosphoinositide formation. MDCK cells were incubated
with 1 tM [3H]-15-HETE for 15 to 120 minutes. Maximum uptake
occurred between 15 and 30 minutes, and after 60 minutes, 70% of the
incorporated 15-HETE was present in the phosphatidylinositol (P1)
fraction. Some 15-HETE was also incorporated into phosphatidylinosi-
tol-4-monophosphate (PIP) and phosphatidylinositol-4,5-bisphosphate(PIP2). However, even though more 15-HETE than arachidonic acid
was incorporated into P1, the fractional amount of 15-HETE present in
the polyphosphoinositides was smaller than arachidonic acid. There-
fore, although l5-HETE is selectively channeled into P1, conversion of
P1 species containing 15-HETE to PIP and PIP2 is relatively impaired.
This suggests that either P1 containing 15-HETE is a less effective
substrate for phosphorylation, or P1 containing arachidonic acid is a
preferred substrate. MDCK cells converted 15-HETE to polar metab-
olites that were released into the extracellular fluid. This process may
constitute a renal tubular mechanism for the clearance of 15-HETE and
related lipoxygenase products.
15-Hydroxyeicosatetraenoic acid (l5-HETE) is a lipoxygen-
ase product derived from arachidonic acid [1]. The 15-lipoxy-
genase enzyme converts arachidonic acid into an unstable
hydroperoxy derivative, 1 5-hydroperoxyeicosatetraenoic acid,
which is then reduced to form 15-HETE. 15-HETE has been
shown to inhibit glucose mediated insulin secretion by pancre-
atic islet cells [2], inhibit renin secretion from renal cortical
slices [3], modulate cyclooxygenase in human umbilical vein
endothelial cells [4], and antagonize the pro-inflammatory ac-
tivity of leukotrienes [5].
Many different cells including eosinophils, reticulocytes, and
macrophages produce 15-HETE. Invasion of the renal paren-
chyma by activated macrophages and/or eosinophils would
likely result in the renal epithelia being exposed to high con-
centrations of 15-HETE. Although we have previously de-
scribed the interaction of 5- and 12-HETE with renal epithelial
cells [6, 71, no information is currently available describing
renal epithelial cell interaction with 15-HETE. Previous reports
have demonstrated selective enrichment of l5-HETE in the
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important phospholipid signaling molecule, phosphatidylinosi-
tol (P1), as well as in phosphatidylinositol-4-monophosphate
(PIP) and phosphatidylinositol-4,5-bisphosphate (PIP2) [8—111.
Since P1 and the polyphosphoinositides play such a pivotal role
in signal transduction, enrichment of the renal tubular epithe-
hum with 15-HETE could significantly alter production of
diacylglycerol and inositol trisphosphate, crucial second mes-
sengers derived from the inositol phospholipids.
The purpose of the present work was to investigate the
uptake, distribution, and metabolism of 15-HETE, with special
emphasis on its incorporation into P1 and the polyphospho-
inositides of renal tubular epithehium. Madin-Darby canine
kidney (MDCK) cells were utilized because they are a fre-
quently studied model for renal tubular epithelium and also
have been previously utilized to investigate inositol phospho-
lipid hydrolysis following bradykinin-mediated phospholipase C
activation [12].
Methods
Cell culture
MDCK cells were obtained from American Type Culture
Collection (ATCC, Rockville, Maryland, USA) and stored in
liquid nitrogen with 7% dimethyl sulfoxide and 20% fetal bovine
serum. Cells were studied between passages 55 and 80 and
maintained according to methods previously described [7]. The
cells were grown in tissue culture flasks with 75 cm2 surface
area (Corning Glass Works, Corning, New York, USA), har-
vested with trypsin and 0.02% EDTA, and subsequently pas-
saged onto six-well tissue culture plates with a surface area of
10 cm2/well (Corning Glass Works). Experiments were per-
formed when the cultures were confluent and formed domes
characteristic of MDCK cells. Cells were grown in Eagle's
minimal essential medium (MEM) with Earle's Salts and 20%
heat-inactivated fetal bovine serum (HyClone, Logan, Utah,
USA). The medium was supplemented with MEM nonessential
amino acids and MEM vitamin solution (GIBCO, Grand Island,
New York, USA), glutamine (2 mM), gentamicin (50 p.g/ml),
and it was buffered to pH 7.4 by adding 1.5 M N-2-hydroxyeth-
ylpiperazine-N'-2-ethane-sulfonic acid (HEPES) and 7.5%
NaHCO3. Cultures were placed in a temperature- and humidity-
controlled incubator (NuAire IR Auto Flow, NuAire, Ply-
mouth, Minnesota, USA) at 37°C with 95% air-5% CO2 as the
gas phase. The protein content of confluent cultures was
measured according to the Lowry method as modified by Lees
and Paxman [13].
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Preparation of media containing hydroxyeicosanoids and
arachidonic acid
The amount of 5-, 12-, or 15-(S)-hydroxy-[5,6,8,9,1i,12,14,
15(n)-3H]-eicosatetraenoic acid (172 Cilmmol, New England
Nuclear, Wilmington, Delaware, USA) added to each culture
varied from 0.1 to 0.4 Ci/ml. Nonradiolabeled 5-, 12-, or
15-HETE [5-, 12-, or 15-(S)-HETE, 0.5 mg/mI, Cayman Chem-
ical, Ann Arbor, Michigan, USA], 50 to 100 jig, was dried under
N2 and resuspended in 100 to 200 .d of 95% ethanol. This was
added at concentrations between 1 and 15 M. Additional
experiments with 15-HETE alone were carried out at concen-
trations between 1 n and 100 flM. 0.1 to 0.4 CiJmI [5,6,8,
9,11,12,14, 15-3H]-arachidonic acid (222 Cilmmol, New England
Nuclear) was combined with 1 M arachidonic acid (Nu-Check
Prep, Elysian, Minnesota, USA). Non-radiolabeled arachidonic
acid was also prepared in concentrations ranging from 0.5 to 15
/LM. Each of these compounds was added to serum-free modi-
fied Eagle's MEM.
Incubation and cell lipid analysis
Individual cultures were incubated at 37°C with one of the
radioactive substrates for up to two hours. The competition
between 15-HETE and arachidonic acid was investigated dur-
ing 60 minute incubations. After removal of the medium, the
cells in each well were washed with I ml of ice-cold Dulbecco's
phosphate-buffered saline (DPBS), scraped with a rubber po-
liceman after addition of 2 ml of ice-cold methanol-i % acetic
acid and aspirated into a siliconized glass centrifuge tube. Cell
lipids were extracted according to the method of Schacht [14].
Two ml of chloroform and 2 ml of 2.4 N HCI were added to each
sample, and the resulting mixture was vortexed and centrifuged
for 10 minutes at 3000 rpm (800 x g) to separate the phases. The
lower chloroform phase was then removed by aspiration and
the remaining upper phase was extracted again with 2 ml of
chloroform as above. The chloroform phases were combined
and washed with 4 ml of methanol-i N HC1 1:1 (vol/vol). The
resulting mixture was mixed vigorously, centrifuged for 10
minutes at 3000 rpm (800 x g), and the chloroform phase
aspirated into siliconized tubes. This volume was dried under
N2 and resuspended in 500 1.d of chloroform-methanol 2:1
(vollvol). A 25 1u1 aliquot from this lipid sample was placed in a
scintillation counter tube, allowed to air dry, and resuspended
in 5 ml of Budget-Solve Scintillation Fluid (Research Products
International Corp.). Radioactivity was measured in an LS 7000
liquid scintillation spectrometer (Packard Instrument Com-
pany, Downers Grove, Illinois, USA) and quenching was
monitored utilizing a 226Ra external standard.
Aliquots of the cell lipid extract containing a minimum of
10,000 dpm were placed on silica gel thin-layer chromatography
(TLC) plates (LK-5D TLC plates, Whatman Chemical Separa-
tion, Clifton, New Jersey, USA) to separate the individual
phospholipid classes from the neutral lipids using sequential
solvent systems consisting of chloroform-methanol-acetic acid-
water 50:50:2:1.5 (vollvollvollvol) and heptane-ethyl ether-ace-
tic acid 75:60:1.5 (vollvol/vol). Labeled and non-radiolabeled
standards were added to the TLC plates. After the solvent front
migrated for 10 cm, the plates were removed, dried, and then
developed in the heptane-ether-acetic acid solvent. The radio-
activity present in the fatty acid and lipid bands was measured
utilizing a TLC plate scanner (Model RS, Radiomatic Instru-
ments, Meriden, Connecticut, USA). After scanning, the re-
maining lanes were visualized under ultraviolet light utilizing
1 mM aqueous 8-anilino-i-naphthalene sulfonic acid (Sigma
Chemical Co., St. Louis, Missouri, USA).
To more completely separate PT from the other phospholipid
classes, cell lipid extracts were analyzed via TLC in a solvent
system consisting of chloroform-methanol-40% methylamine,
60:36:5, (vol/vollvol) [15]. Bands having the same Rf value as
standard phosphatidylinositol (P1) were scraped from each lane
into 4 ml of acidified 0.9% NaC1 solution. Mter 30 minutes, 9 ml
of chloroform-methanol 1:1, (vol/vol) was added, the mixture
was vortexed thoroughly and centrifuged for 10 minutes at 3000
rpm (800 x g) to separate the phases. With a siliconized Pasteur
pipette, the lower chloroform phase of each sample was aspi-
rated into a second siliconized tube. Any remaining lipids were
extracted again from the silica gel by addition of S ml of
chloroform to the remaining aqueous phase and processed as
above. The chloroform phases for each sample were combined,
dried under N2, and resuspended in 500 jsl of chloroform-
methanol 2:1, (vol/vol). A 25 1.d aliquot from each sample was
placed in a scintillation vial, allowed to air dry, resuspended in
S ml of Budget-Solve scintillation solution, and assayed for
radioactivity. Aliquots of the cellular lipid extract containing a
minimum of 10,000 dpm also were added to potassium oxalate-
impregnated TLC plates according to the method of Jolles et al
[16]. The lipids were separated with a solvent system of
chloroform-methanol-water-ammonium hydroxide 50:35:6.5:3,
(vollvollvol/vol) [17] designed to separate the inositol-contain-
ing phospholipids into their components, P1, PIP, and PIP2. The
chromatograms were analyzed for radioactivity as described
above, and the bands on the silica gel corresponding to the
polyphosphoinositides were then scraped into scintillation vials
containing Budget-Solve solution (Research Products Interna-
tional) and radioactivity was measured in a liquid scintillation
spectrometer.
Phospholipase A2 hydrolysis and analysis of liberated
fatty acid
To determine the positional specificity of l5-HETE incorpo-
ration into phospholipids, aliquots from extracted cell lipids
labeled with 1 M [3H]-15-HETE were dried under N2 and
resuspended in 50 d diethyl ether. Twenty-five d of 0.1 M
Tris-HCI, pH 6.8, 25 d of 0.1 M sodium borate and 50 d of 0.5
mg/mi phospholipase A2 (Naja naja, Sigma Chemical Company)
in 4 mM CaCI2 were added, and the mixture was incubated with
shaking in a bath for 45 minutes at 37°C. The reaction was
terminated with the addition of 20 sl of 0.1 M EDTA and the
suspension dried under N2 and resuspended in 75 .d of chloro-
form-methanol 1:1 (vollvol). The entire sample was spotted on
silica gel TLC plates and the lipids separated with a solvent
system of hexane-ethyl ether-acetic acid 75:75:1.5 (vollvol/vol)
designed to separate free fatty acids from phospholipids and
lysophospholipids. The radioactivity present in the fatty acid
and lysophospholipid bands was localized by scanning with the
TLC plate scanner. Segments of silica gel corresponding to the
major bands of radioactivity were scraped from the TLC plates
and placed in scintillation vials containing 4 ml of Buget Solve
scintillation solution (Research Products International). Radio-
activity was measured in a liquid scintillation spectrometer.
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To determine the form of the 15-HETE radioactivity incor-
porated into MDCK cell lipids, a separate aliquot of the cell
lipid extract was hydrolyzed with phospholipase A2, and the
resulting mixture was dried and resuspended in 30 d acetoni-
trile and 70 pi water containing phosphoric acid, pH 3.4, and
injected into a reverse-phase high-performance liquid chro-
matograph (HPLC). The Beckman 332 chromatograph con-
tained a 4.6 x 250 mm Beckman column with C18 reverse-phase
5 sm spherical packing. The solvent mixture consisted of water
adjusted to pH 3.4 with phosphoric acid and had an increasing
acetonitrile gradient from 27 to 100% over 45 minutes. Radio-
activity was detected by mixing the column effluent with
Budget-Solve scintillation solution using the Radiomatic HPLC
radioactivity flow detector and software (Radiomatic Flo One
Beta, Radiomatic, Meriden, Connecticut, USA).
Assay of incubation medium
To determine whether MDCK cells convert 15-HETE into
metabolic products, 1 p.M [3H]-15-HETE (0.1 p.Ci/ml) was
incubated with MDCK cells for 15 to 120 minutes. As a control,
fatty acid containing medium was incubated in the absence of
cells. At the appropriate times, the medium was removed and
ethyl acetate 2:1 (vol/vol) was added to each sample. Twenty p.1
of 2.4 N HCI was added, and the samples were then vortexed
and centrifuged at 3000 rpm (800 x g) for 10 mm to cleanly
separate the phases. The upper ethyl acetate phases were
aspirated into a second set of siliconized tubes. Ethyl acetate
was again added to the lower phase, and the process was
repeated for a total of three extractions. The ethyl acetate
phases were combined, dried under N2, and resuspended in 500
p.1 of acetonitrile. A 25 p.1 aliquot was taken from each sample,
air dried, and resuspended in 5 ml of Budget-Solve solution for
measurement of total radioactivity. The remainder, containing
at least 15,000 dpm, was suspended in acetonitrile and acidified
water, and then separated by reverse-phase HPLC.
Reagents and chemicals
Unless otherwise specified all reagents and chemicals were
obtained from Sigma Chemical Company or Fisher Scientific
(Fair Lawn, New Jersey, USA).
Results
15-HETE uptake
To investigate 15-HETE uptake by MDCK cells, 1 p.M
[3H]-15-HETE was incubated with the cells for up to two hours.
For comparison, 1 p.M [3H]-5-HETE and 1 /LM [3H]-l2-HETE
were also incubated with MDCK cells for 60 minutes. Figure 1
demonstrates that the uptake of 15-HETE by MDCK cells was
time dependent, with the maximum uptake occurring within 15
to 30 minutes of incubation. Comparison at 60 minutes reveals
that less 15-HETE was taken up as compared to 5- or 12-HETE,
consistent with previous results [61.
The concentration dependence of 15-HETE uptake by
MDCK cells was examined by incubating [3H]-15-HETE with
MDCK cells for 30 minutes over concentrations ranging from
1 to 15 p.M. Figure 2 demonstrates that MDCK cell uptake of
15-HETE increased and was not saturable even at the higher
concentrations.
0 20 40 60 80 100 120
Time, minutes
Fig. 1. Comparison of5-, 12-, and 15-HETE uptake. MDCK cells were
incubated for 15 to 120 minutes with 1 /LM [3H]-15-HETE, and for 60
minutes with I LM [3H]-5- or l2-HETE. At appropriate times, medium
was removed, cells were washed with ice-cold buffer solution, and
lipids were extracted with chloroform/methanol. Aliquots were assayed
for radioactivity, and error bars represent SE for 3 separate cultures.
Symbols are: (0) 5-HETE; (0) l2-HETE; (0) 15-HETE.
To determine the characteristics of 15-HETE uptake at
concentrations likely to be present in the renal interstitium,
MDCK cells were incubated for 60 minutes with concentrations
ranging from 1 n to 100 n (Fig. 2, insert). The uptake by the
MDCK cells also was roughly linear over this lower range of
concentrations.
The competition for uptake between l5-HETE and arachi-
donic acid also was studied in the MDCK cell system. Two
different conditions of competition were tested. In the first set
of experiments, 1 p.M arachidonic acid was added to MDCK
cultures containing either no l5-HETE or [3H]-15-HETE vary-
ing in concentrations from 0.5 to 10 /.LM 15-HETE. Figure 3
(top) indicates that the presence of arachidonic acid did not
reduce 15-HETE uptake (comparing Fig. 3 with Fig. 2). When
1 p.M [3H]-l5-HETE was incubated with increasing concentra-
tions of arachidonic acid varying in concentrations from 0.5 to
15 p.M, 2 components of uptake were seen (Fig. 3, bottom). At
the lower concentrations of arachidonic acid, 15-HETE uptake
was reduced somewhat as compared with the arachidonic
acid-free control. However, arachidonic acid concentrations of
10 and 15 p.M failed to further reduce 15-HETE uptake. Even in
the presence of 15 p.M arachidonic acid, l5-HETE uptake
remained at 75% of the control value.
15-HETE distribution in MDCK cell lipids
After incubation with 1 /LM [3H]-l5-HETE for 30 minutes,
MDCK cell lipids were extracted and the phospholipids and
neutral lipids were separated by TLC. l5-HETE is preferen-
tially incorporated into P1, with very little radioactivity incor-
porated into phosphatidylcholine (PC) or the neutral lipid (NL)
fraction. Analysis of the fractional percentage of incorporation
into each of the major components indicated that 69% was
incorporated into P1, 11% into PC, and 13% into the NL
fraction (data not shown). The distribution of labeled l5-HETE
in the MDCK cell phospholipids during the course of a two
hours incubation is shown in Figure 4. At every time point, the
majority of the 15-HETE in MDCK cell lipids is in P1, with
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Fig. 2. Concentration dependence of 15-HETE uptake. MDCK cells were incubated for 30 minutes with 1 to 15 LM [3H]-15-HETE in serum-free
EMEM. Cell lipids were extracted and aliquots assayed for radioactivity. Error bars represent SE for 3 separate cultures. Insert: Incubation for 60
minutes with 1 to 100 nM [3HJ-15-HETE in serum-free EMEM.
sequentially lesser amounts in PC, phosphatidylethanolamine
(PE), and phosphatidylsenne (PS). By contrast, as is shown in
Figure 5, we found that 5- and 12-HETE are preferentially
incorporated into PC rather than P1 by these cells, a result
consistent with previously published data [61. Thus, 15-HETE
preferentially accumulates in P1, a phospholipid that is much
less abundant than either PC or PE in cell membranes but which
is intimately involved in signal transduction.
Polyphosphoinositide distribution of 15-HETE in MDCK
cell lipids
Since 15-HETE appears to be channeled predominantly into
P1, and given the importance of the P1 cycle in signal transduc-
tion, we sought to determine the distribution of 15-HETE in the
polyphosphoinositides and to compare it with the correspond-
ing unsubstituted polyunsaturated fatty acid, arachidonic acid.
One tM [3H]-15-HETE, and for comparison 1 pM [3H]-arachi-
donic acid, were incubated with MDCK cells for 60 to 120
minutes. Aliquots of the cell lipid extracts were subjected to
TLC using a solvent system designed to separate the more polar
polyphosphoinositides from P1. Figure 6 (top) demonstrates
that more [3H}-15-HETE is present in P1 compared to [3H]-
arachidonic acid. A small but discernible amount of [3H]-l5-
HETE and [3H]-arachidonic acid was also incorporated into the
polyphosphorylated P1 species. Figure 6 (bottom) shows more
clearly the amount of each [3H]-fatty acid contained in the
polyphosphoinositide species. After 60 minutes, more radiola-
bel is found in PIP than in PIP2 for both fatty acids. More
labeled 15-HETE than arachidonic acid is found in both PIP and
PIP2. Furthermore, when the ratio of labeled PIP plus PIP2
relative to labeled P1 is calculated for both 15-HETE and
arachidonic acid, differences between 15-HETE and arachi-
donic acid in these polyphosphoinositides become quite appar-
ent. Figure 7 demonstrates that while this ratio increases
between 60 and 120 minutes for arachidonic acid, it decreases
for 15-HETE so that by 120 minutes there is almost four times
the amount (based on % of radioactivity incorporated) of
arachidonic acid label in polyphosphoinositides as compared
with 15-HETE.
Position and identity of 15-HETE in MDCK
cell phospholipids
To determine the position of esterified 15-HETE in the
MDCK cell lipids, 1 jM [3H]-l5-HETE and, for comparison,
1 ILM [3H]-12-HETE, were incubated with MDCK cells for 60
minutes and the cell lipids were analyzed via TLC following
phospholipase A2 digestion. In addition, to assess completeness
of the phospholipase A2 hydrolysis, a P1 standard containing
['4C]-arachidonic acid in the sn-2 position was subjected to
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phospholipase A2 hydrolysis under identical conditions. Fol-
lowing phospholipase A2 hydrolysis, 77% of the ['4C]-arachi-
donic acid released from the P1 standard co-migrated with a
radiolabeled arachidonic acid standard. In contrast, only 26% of
the 1 5-HETE radioactivity released from the cell lipids follow-
ing phospholipase A2 digestion co-migrated with a known
A
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0 8 9 10 Fig. 5. Distribution of 5-, 12-, and 15-HETE into MDCK cell phospho-
B lipids. MDCK cells were incubated with I [3H]-5-, 12-, or 15-HETE
120 . for 60 minutes. Cell lipids were extracted and separated into their
phospholipid components by TLC. Symbols are: (U) P1; () PC; (U)
PS; () PE'1oo80•
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Fig. 3. Competition for uptake between 15-HETE and arachidonic 50C)
acid. MDCK cells were incubated for 60 minutes with either 1 M
arachidonic acid and 1 to 10 /.tM [3H]-15-HETE (A) or I tM [3H1-15-
— 0
HETE and 1 to 15 LM arachidonic acid (B) in serum-free EMEM. Cell
lipids were extracted and aliquots assayed for radioactivity. Error bars
represent SE for 3 separate cultures.
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Fig. 4. Time dependence of 15-HETE distribution in the phospholipids. Fig. 6. Polyphosphoinositide distribution of 15-HETE in MDCK cell
MDCK cells were incubated for 15 to 120 minutes with M [3H]-15- lipids. One LM 3H] 15-HETE or 1 LM [3H] arachidonic acid wasHETE. At appropriate times, medium was removed, cells were washed incubated with MDCK cells for 60 minutes. Aliquots from cell lipid
with ice-cold buffer solution, and lipids were extracted with chloroform! extracts were analyzed via TLC. B. An expanded representation of the
methanol. Aliquots from these extracts were analyzed via TLC utilizing fatty acid is distributed among the polyphosphoinositides. Error bars
a solvent system that separates the phospholipids. Error bars represent represent SE for 3 separate cultures. Symbols are in A: (U) P1; () PIP;
SE for 3 separate cultures. Symbols are: (0) P1; (0) PC; () PS; (x) PE. (U) PIP2. Symbols are in B: () PIP; (0) PIP2.
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Fig. 7. Time dependence of radioactive polyphosphoinositide incorpo-
ration of arachidonic acid (1) and 15-HETE (•). One M [3H}
15-HETE or 1 /sM PH] arachidonic acid was incubated with MDCK
cells for 60 to 120 minutes. Aliquots from cell lipid extracts were
analyzed via TLC. The values represent the fraction of the labeled
arachidonic acid or 15-HETE in PIP plus PIP2 relative to P1, denoted as
the radioactivity ratio, after 60 or 120 minutes of incubation.
15-HETE standard. When 12-HETE was analyzed under iden-
tical conditions, 29% of the 12-HETE radioactivity which was
released from the cells lipids co-migrated with a known 12-
HETE standard (data not shown).
A separate sample of the cell lipid extract containing [3H]-
15-HETE was incubated with phospholipase A2 and then as-
sayed by reverse-phase HPLC. Figure 8 demonstrates that
several peaks of radioactivity are detected following treatment
with phospholipase A2 (top). The major peak, which represents
58% of the incorporated radioactivity, migrates at 23.9 minutes
and has an identical retention time to a 15-HETE standard
(bottom). The identity of the other main peak migrating at 36.5
minutes was not determined. Thus it appears that the majority
of the l5-HETE is incorporated into the cell lipids without
chemical modification.
Metabolism of 15-HETE by MDCK cells
To determine if MDCK cells can carry out any chemical
modification of 15-HETE, 1 C.M [3H1-l5-HETE was incubated
with MDCK cells for 60 to 120 minutes. As a control, 1 /SM
['H]-15-HETE was also incubated in a cell-free medium for 120
minutes. Figure 9 (top) demonstrates that in the absence of
cells, no conversion of 15-HETE (retention time = 23.9 mm) to
other labeled products takes place. The subsequent two chro-
matograms demonstrate a time-dependent conversion of 15-
HETE into several more polar metabolites recovered in the
medium during incubation with the MDCK cells. At 60 minutes,
some unmodified 15-HETE remains in the medium, but most of
the 15-HETE radioactivity is converted into more polar metab-
olites including two prominent metabolites with retention times
of 15.6 and 11.4 minutes, respectively. After 120 minutes of
incubation, the MDCK cells converted almost all of the 15-
HETE into polar metabolites, with most of the radioactivity
eluting in the 11.4 minute peak. The HPLC properties of these
15-HETE metabolites resemble those of the major 15-HETE
polar metabolites released by endothelial cells, which are
thought to be produced by two sequential rounds of peroxiso-
mal /3-oxidation [9].
0 0 5 10 15 20 25 30 35 40 45
Time, minutes
Fig. S. Identity of 15-HETE radioactivity in MDCK cell phospholipids.
OneM [3H]-15-HETE was incubated with MDCK cells for 1 hour. The
cell lipids were extracted and then subjected to phospholipase A2
hydrolysis for 45 minutes. The resulting mixture was separated by
reverse-phase HPLC. The retention time for 15-HETE in this system is
23.9 minutes. The top panel shows the distribution of 15-HETE
radioactivity (dpm) in the cell lipids after incubation with phospholipase
A2. The lower panel illustrates the retention time of l'H]-15-HETE and
related radioactive standards in this system.
Discussion
In renal inflammatory disorders involving either the glomer-
ulus or renal interstitium, neutrophils and macrophages are the
predominant inflammatory cells recruited to these areas of the
nephron [5]. Several studies have previously addressed the
relationship between these inflammatory cells and 15-HETE [5,
10, 18—21]. For example, when pre-incubated with neutrophils,
15-HETE has been shown to markedly dampen the respiratory
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200 Fig. 9. Time dependent metabolism of 15-HETE by MDCK cells. One
15-HETE Empty dish /LM [3H]45.HETE was incubated with MDCK cells for 60 or 120minutes, and the lipids were extracted from the medium with ethyl
acetate. Aliquots from medium extracts were assayed by reverse-phase
HPLC. The retention time for 15-HETE in this system is 23.9 minutes.
150 The uppermost panel is a chromatogram of [3H]- 15-HETE radioactivity(dpm) in the medium after incubation for 120 minutes without cells. The
subsequent two chromatograms show the distribution of radioactivity in
the medium following incubation of [3H]-l5-HETE with the cells for 60
and 120 minutes, respectively.
100
burst capacity [10] and abolish the chemotactic responses to
leukotriene B4 [21], the most potent chemotactic substance yet
50 described for this cell [221. Furthermore, 15-HETE is produced
when glomeruli, isolated from rat kidneys after administration
of nephrotoxic serum, are stimulated with ionophore A23 187.
The amount of 15-HETE produced by these glomeruli was five
200 iJLI1_E-IL.hiIJ1J,d times greater than the quantity of LTB4 at three hours andincreased over the next two weeks. Although the origin of60 minutes 15-HETE could not be determined, it is highly likely that the
source was an infiltrating inflammatory cell such as the macro-
phage [5]. Thus, although these studies have assessed the
150 production of 15-HETE in renal inflammation, none have
carefully examined the interaction between 15-HETE and ei-
ther renal epithelial or glomerular cells.
While other eicosanoids such as prostaglandins affect cell
function by binding to plasma membrane receptors, HETE's
: 100 are incorporated into membrane lipids and thus exert theireffects through a different mechanism [23, 24]. When unsubsti-
tuted polyunsaturated fatty acids are replaced in the sn-2
position by one of the HETEs, acyl chain packing relationships
may be perturbed, and as a consequence, membrane properties
1 5-HETE altered [1]. Thus, to gain some insight into the potential role that
50 15-HETE may play when it interacts with renal epithelial cells,
we studied the uptake, distribution, and metabolism of 15-
HETE by a cultured renal tubular epithelial cell line.
200
Following uptake of 15-HETE into MDCK cells, we find that
______
it is rapidly incorporated in unmodified form into P1. We
120 minutes thought that 15-HETE, like other polyunsaturated fatty acids,
would be incorporated into the sn-2 position of P1. However,
only 26% of the P1 radioactivity incorporated into MDCK cell
lipids was released during incubation with phospholipase A7. In
150 similar fashion, MDCK cell lipids containing [3H]-12-HETE
released only 29% of the radioactivity following treatment with
phospholipase A2. The majority of the radioactivity for both 12-
and 15-HETE hydrolysis by phospholipase A2 remained in the
100 phospholipid fraction. There are two explanations which might
account for this observation. First, it is possible that 15-HETE
was esterified into the sn-i position of the glycerol backbone.
This seems unlikely in view of our previously published work
demonstrating that two related lipoxygenase products, 5- and
50 12-HETE, are preferentially esterified into the sn-2 position of
MDCK cell phospholipids [6, 7]. Likewise, 15-HETE is also
preferentially esterified into the sn-2 position of P1 in other cell
systems [10, 111. Alternatively, since phospholipase A2 is
known to have substrate preferences dependent on the phos-0
0 5 10 15 20 25 30 35 40 45 pholipid class and molecular species, it is possible that under
the conditions that we utilized, phospholipid hydrolysis of
Time, minutes MDCK cell phospholipids containing 15-HETE (and 12-HETE)
by phospholipase A2 did not go to completion. Evidence
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supporting this is that a P1 standard containing ['4C]-arachidon-
ic acid in the sn-2 position, incubated under identical condi-
tions, was hydrolyzed nearly threefold greater than either the
12- or 15-HETE samples.
Similar results demonstrating preferential 15-HETE incorpo-
ration into P1 have been observed in other cell systems [8—11,
22, 25—27]. Legrand et al found that when endothelial cells were
supplemented every two hours with fresh medium containing
15-HETE, the uptake was not saturable for up to eight hours
[11]. These investigators demonstrated that the 15-HETE was
nearly entirely incorporated into phospholipids, with 30% of the
total added radioactivity being recovered in P1 after two hours.
They also used mass spectrometry to show that after two hours,
l5-HETE is esterified in the sn-2 position of P1 to form either
1-steroyl-2-(15-HETE)-PI or 1-oleoyl-2-(15-HETE)-PI. Brezin-
ski et al found that neutrophils incorporate 20% of the available
15-HETE into P1 in 20 minutes, while less than 4% goes into
other phospholipid classes or the neutral lipids [10]. These data
are consistent with the present results indicating that like
endothelial cells and neutrophils, MDCK cells esterify 15-
HETE primarily into P1, a membrane phospholipid involved in
signal transduction.
We also determined that a small amount of the 15-HETE
taken up by MDCK cells is distributed to PIP and PIP2,
indicating that the incorporation of 15-HETE does not abolish
P1 phosphorylation. Similar results have been obtained in other
cultured cell lines [8, 10]. For example, N1E-115 murine
neuroblastoma cells very rapidly incorporated small amounts
(2% of the radioactivity in P1) of [3H]-15-HETE into PIP and
PIP2 [81. Small amounts of radioactively labeled PIP and PIP2
also were detected as early as 30 seconds following exposure of
human neutrophils to [3H]-l5-HETE [10]. Since less 15-HETE
is channeled into the polyphosphoinositides PIP and PIP2
relative to P1 than arachidonic acid (Fig. 6), it is possible that
the presence of 15-HETE in the sn-2 position of P1 inhibits the
phosphorylation of P1. Alternatively, the lesser fraction of
15-HETE in PIP and PIP2 relative to P1 at both at 60 and 120
minutes might indicate that in MDCK cells, P1 containing
arachidonic acid in the sn-2 position is the preferred substrate
for phosphorylation. In this context, previous work in the
Friend erythroleukemia cell line has indicated an absolute
requirement for arachidonic acid in P1 for polyphosphorylation
to occur [281.
Regardless of the mechanism accounting for the reduced
fractional conversion of P1 to the polyphosphoinositides, the
presence of 15-HETE may reduce cellular responses produced
through PT cycle activation by making less substrate available
for agonist mediated phospholipase C hydrolysis. This hypoth-
esis is consistent with findings of Dudley et al, who determined
that following stimulation of GH3 cells pretreated with 15-
HETE, less diacylglycerol was produced [29].
We found that, similar to what has been described in other
cell systems, 15-HETE is converted to more polar metabolites
which are released into the extracellular medium. Using HPLC
and mass spectrometry, Shen et al demonstrated the gradual
production of two polar metabolites of 15-HETE [9]. The more
prominent metabolite was identified as 1 1-hydroxyhexadecatri-
enoic acid [16:3(11-OH)]. Alpert and Walenga demonstrated
that several polar metabolites of 15-HETE were also produced
by tracheal epithelial cells [27]. These 15-HETE polar metabo-
lites, similar to the major polar metabolites derived from
12-HETE, are most likely formed via two cycles of peroxisomal
/3-oxidation [30, 31]. This process in the renal tubular epithe-
hum likely represents a mechanism for inactivation and clear-
ance of this lipoxygenase product.
These studies therefore indicate that renal tubular epithelial
cells have a considerable capacity for 15-HETE uptake and, as
opposed to what has been shown with 5- and 12-HETE,
selectively esterify this lipoxygenase product into P1. The
presence of 15-HETE in P1 reduces its subsequent phosphory-
lation into PIP and PIP2, and this could potentially alter the
amount and/or rate of production of the second messenger
molecules diacylglycerol and inositol trisphosphate. The rela-
tively rapid conversion of 15-HETE to more polar metabolites
and their subsequent release into the extracellular medium
support the role of the renal tubular epithelium as a site for
clearance of this inflammatory mediator. Thus the renal epithe-
hum may offer some protection against local 15-HETE release
by inflammatory cells that enter the kidney parenchyma in the
setting of acute inflammation.
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Appendix. Abbreviations
HETE, hydroxyeicosatetraenoic acid; TLC, thin layer chromatogra-
phy; HPLC, high pressure liquid chromatography; PC, phosphatidyl-
choline; P1, phosphatidylinositol; PE, phosphatidylethanolamine; PS,
phosphatidylserine; PIP, phosphatidylinositol-4-monophosphate; PIP2,
phosphatidylinositol-4,5-bisphosphate; MDCK, Madin-Darby canine
kidney; EMEM, Eagle's modified essential medium; DPBS, Dulbeco's
phosphate-buffered saline.
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